SHIONOGI PHARMA CO., LTD.

Shionogi Completes Acquisition of Japan Tobacco's Pharmaceutical Business and Plans Manufacturing Subsidiary Merger

- Shionogi has completed the succession of Japan Tobacco Inc.'s pharmaceutical business and acquisition of Akros Pharma Inc. shares through a simplified absorption-type company split. - The Japanese pharmaceutical company announced plans to merge with its wholly owned manufacturing subsidiary Shionogi Pharma Co., Ltd., effective April 1, 2027. - The merger aims to strengthen functional collaborations and build a robust production and supply system to adapt to environmental changes in the pharmaceutical supply chain. - Shionogi is accelerating globalization and business expansion primarily focused on in-house discovered infectious disease products under its SHIONOGI Transformation Strategy 2030 Revision.